Correctly determining whether a product is regulated as a cosmetic, drug, or OTC hybrid is one of the most critical steps for companies entering the U.S. market. Misclassification can lead to FDA enforcement actions, product recalls, detentions at ports, and costly re-labeling or reformulation. The U.S. FDA defines cosmetics as [...]